Intrinsic Value of S&P & Nasdaq Contact Us

Tesaro, Inc. TSRO NASDAQ

NASDAQ • Healthcare • Biotechnology • USD

SharesGrow Score
32/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Tesaro, Inc. (TSRO) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 30/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
32/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — TSRO

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio18.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-9.17
Book Value / Share$0.00
Revenue / Share$4.13
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2011 $-1.72 $0.00 $-16.4M -
2012 $-4.51 $0.00 $-61.76M -
2013 $-2.92 $0.00 $-92.28M -
2014 $-4.83 $0.00 $-172.54M -
2015 $-6.54 $317K $-257.46M -81218.3%
2016 $-8.13 $44.82M $-387.47M -864.4%
2017 $-9.17 $223.33M $-496.13M -222.2%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message